Objective: To evaluate the effect of the hormone replacement therapy type estradiol-medroxyprogesterone and tibolona on cardiovascular system, bone mass and memory in the climacteric patients.
Patients And Method: From January through December 2001 at the Specialties Hospital No. 1, we included 77 consecutive climacteric patients.